We are live on ! Find out more
Walleye Capital

Walleye Capital Portfolio holdings

AUM $28B
1-Year Est. Return 44.22%
This Fund
S&P 500
This Quarter Est. Return
+23.06%
1 Year Est. Return
+44.22%
3 Year Est. Return
+129.23%
5 Year Est. Return
+202.08%
10 Year Est. Return
AUM
$28B
AUM Growth
+$3.95B
Cap. Flow
+$1.25B
Cap. Flow %
4.46%
Top 10 Hldgs %
30.24%
Holding
5,293
New
979
Increased
1,668
Reduced
1,868
Closed
619

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.05B
2
AMZN icon
Amazon
AMZN
+$170M
3
ABNB icon
Airbnb
ABNB
+$115M
4
NVDA icon
NVIDIA
NVDA
+$112M
5
ASML icon
ASML
ASML
+$87M

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.72%
2 Technology 11.48%
3 Industrials 7.26%
4 Financials 7.22%
5 Consumer Discretionary 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WALDW icon
4351
Waldencast PLC Warrant
WALDW
$807K
$17.8K ﹤0.01%
379,729
EVGO icon
4352
PUT
EVgo
EVGO
$200M
$17.8K ﹤0.01%
+9,300
New +$18.7K
FRPT icon
4353
CALL
Freshpet
FRPT
$3.01B
$17.7K ﹤0.01%
300
+200
+200% +$11.4K
SAM icon
4354
PUT
Boston Beer
SAM
$1.76B
$17.7K ﹤0.01%
+100
New +$20.3K
HCC icon
4355
Warrior Met Coal
HCC
$4.84B
$17.7K ﹤0.01%
218
-13,955
-98% -$1.26M
TTAN
4356
ServiceTitan Inc
TTAN
$5.65B
$17.6K ﹤0.01%
249
-12,895
-98% -$830K
ZTO icon
4357
ZTO Express
ZTO
$15.4B
$17.5K ﹤0.01%
+784
New +$18.7K
TMDX icon
4358
Transmedics
TMDX
$3.05B
$17.5K ﹤0.01%
264
-1,949
-88% -$165K
CORT icon
4359
CALL
Corcept Therapeutics
CORT
$12B
$17.4K ﹤0.01%
200
-3,600
-95% -$217K
XYL icon
4360
Xylem
XYL
$25.1B
$17.4K ﹤0.01%
147
-484
-77% -$55.9K
NMRA icon
4361
CALL
Neumora Therapeutics
NMRA
$156M
$17K ﹤0.01%
10,000
+1,500
+18% +$2.86K
MED icon
4362
PUT
Medifast
MED
$134M
$17K ﹤0.01%
+1,600
New +$18.5K
PTLO icon
4363
PUT
Portillo's
PTLO
$280M
$16.6K ﹤0.01%
+3,500
New +$16.9K
OPFI.WS
4364
DELISTED
OppFi Inc Warrants
OPFI.WS
$16.5K ﹤0.01%
550,240
-7,236
-1% -$872
DTE icon
4365
DTE Energy
DTE
$27.1B
$16.5K ﹤0.01%
108
-1,828
-94% -$267K
PENN icon
4366
PENN Entertainment
PENN
$2.38B
$16.3K ﹤0.01%
764
-7,049
-90% -$126K
GEHC icon
4367
GE HealthCare
GEHC
$28.9B
$16.3K ﹤0.01%
254
-10,017
-98% -$658K
AMLX icon
4368
CALL
Amylyx Pharmaceuticals
AMLX
$3.69B
$16.2K ﹤0.01%
900
-5,400
-86% -$83.5K
CNR
4369
PUT
Core Natural Resources Inc
CNR
$4.69B
$16K ﹤0.01%
200
-10,700
-98% -$948K
SANM icon
4370
Sanmina
SANM
$10.3B
$15.9K ﹤0.01%
63
-1,098
-95% -$241K
VIPS icon
4371
PUT
Vipshop
VIPS
$5.75B
$15.9K ﹤0.01%
+1,200
New +$17.1K
IQV icon
4372
IQVIA
IQV
$44.4B
$15.8K ﹤0.01%
82
+61
+290% +$10.6K
EXEL icon
4373
Exelixis
EXEL
$14.1B
$15.8K ﹤0.01%
291
-613
-68% -$29.8K
ES icon
4374
Eversource Energy
ES
$25.3B
$15.8K ﹤0.01%
218
-650
-75% -$45K
WMS icon
4375
CALL
Advanced Drainage Systems
WMS
$9.59B
$15.7K ﹤0.01%
+100
New +$14.3K

Similar funds

Walleye Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Walleye Capital held 5,293 positions worth $28B, up 16% from $24B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Walleye Capital deployed $1.25B of net new capital in Q2 2026, opening 979 new positions and adding to 1,668 existing holdings. Its largest new stake was State Street SPDR Portfolio S&P 500 ETF: 20,509,091 shares worth $1.8B.

By sector, the portfolio is most concentrated in Miscellaneous at 57% of assets, down from 59% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.05B trimmed.

  • Walleye Capital's largest Q2 2026 buy was State Street SPDR Portfolio S&P 500 ETF: 20,509,091 shares worth $1.8B.
  • Walleye Capital added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $642M increase.
  • Walleye Capital's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.05B.
  • Walleye Capital fully exited Garmin in Q2 2026, selling an estimated $53.3M.
  • Walleye Capital's ten largest holdings make up 30% of its $28B portfolio in Q2 2026.
  • Walleye Capital opened 979 new positions and closed 619 in Q2 2026.
  • Walleye Capital's portfolio value rose 16% quarter-over-quarter to $28B.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.